**Author details**

Teresa Auguet1 \*, Laia Bertran<sup>2</sup> and Jessica Binetti1

1 Internal Medicine Department, University Hospital of Tarragona Joan XXIII, Rovira and Virgili University, Institut d'Investigació Sanitària Pere Virgili, Tarragona, Spain

2 Medicine and Surgery Department, Rovira and Virgili University, Institut d'Investigació Sanitària Pere Virgili, Tarragona, Spain

\*Address all correspondence to: tauguet.hj23.ics@gencat.cat

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**57**

*Intestinal Dysbiosis and Non-Alcoholic Fatty Liver Disease*

and non-alcoholic fatty liver disease: New insights. Clinical Microbiology and Infection. 2013;**19**(4):338-348. DOI:

[9] Gangarapu V, Yildiz K, Tuzun Ince A, Baysal B. Role of gut microbiota: Obesity and NAFLD. The Turkish Journal of Gastroenterology. 2014;**25**(2):133-140.

[10] Shen F, Zheng R-D, Sun X-Q, Ding W-J, Wang X-Y, Fan J-G. Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease. Hepatobiliary & Pancreatic Diseases International. 2017;**16**(4):375-381. DOI: 10.1016/

[11] Janssen S, Depoortere I. Nutrient sensing in the gut: New roads to therapeutics? Trends in Endocrinology and Metabolism. 2013;**24**(2):92-100. DOI: 10.1016/j.tem.2012.11.006

[12] Okubo H et al. Roles of gut-derived secretory factors in the pathogenesis of non-alcoholic fatty liver disease and their possible clinical applications. International Journal of Molecular Sciences. 2018;**19**(10):3064. DOI:

10.1111/1469-0691.12140

DOI: 10.5152/tjg.2014.7886

S1499-3872(17)60019-5

10.3390/ijms19103064

jhep.2006.06.013

s10620-009-1081-0

[13] Imajo K, Yoneda M, Ogawa Y, Wada K, Nakajima A. Microbiota and nonalcoholic steatohepatitis. Seminars in Immunopathology. 2014;**36**(1):115- 132. DOI: 10.1007/s00281-013-0404-6

[14] Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histology in obese patients undergoing bariatric surgery. Journal of Hepatology. 2006;**45**(4):600-606. DOI: 10.1016/j.

[15] Lewis JR, Mohanty SR. Nonalcoholic fatty liver disease: A review and update.

Digestive Diseases and Sciences. 2010;**55**(3):560-578. DOI: 10.1007/

*DOI: http://dx.doi.org/10.5772/intechopen.92972*

[1] Cotter TG, Rinella M. NAFLD 2020: The state of the disease.

[3] Ekstedt M et al. Long-term

Gastroenterology. 2020;**158**:1851-1864. DOI: 10.1053/j.gastro.2020.01.052

[2] Younossi ZM et al. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology. 2016;**64**(5): 1577-1586. DOI: 10.1002/hep.28785

follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;**44**(4):865-873. DOI: 10.1002/

[4] Chalasani N et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology and the American Gastroenterological Association. The American Journal of Gastroenterology. 2012;**107**(6):811-826. DOI: 10.1038/

[5] El-Badry AM et al. Assessment of hepatic steatosis by expert pathologists: The end of a gold standard. Annals of Surgery. 2009;**250**(5):691-696. DOI: 10.1097/SLA.0b013e3181bcd6dd

[6] Aragonès G et al. Circulating microbiota-derived metabolites: A "liquid biopsy?". International Journal of Obesity. 2019;**44**:875-885. DOI: 10.1038/s41366-019-0430-0

[7] Carter-Kent C, Zein NN, Feldstein AE. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: Implications for treatment. The American Journal of Gastroenterology.

2008;**103**(4):1036-1042. DOI: 10.1111/j.1572-0241.2007.01709.x

[8] Aron-Wisnewsky J, Gaborit B, Dutour A, Clement K. Gut microbiota

**References**

hep.21327

ajg.2012.128

*Intestinal Dysbiosis and Non-Alcoholic Fatty Liver Disease DOI: http://dx.doi.org/10.5772/intechopen.92972*
